Cargando…

Different humoral but similar cellular responses of patients with autoimmune inflammatory rheumatic diseases under disease-modifying antirheumatic drugs after COVID-19 vaccination

OBJECTIVES: The effect of different modes of immunosuppressive therapy in autoimmune inflammatory rheumatic diseases (AIRDs) remains unclear. We investigated the impact of immunosuppressive therapies on humoral and cellular responses after two-dose vaccination. METHODS: Patients with rheumatoid arth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andreica, Ioana, Blazquez-Navarro, Arturo, Sokolar, Jan, Anft, Moritz, Kiltz, Uta, Pfaender, Stephanie, Vidal Blanco, Elena, Westhoff, Timm, Babel, Nina, Stervbo, Ulrik, Baraliakos, Xenofon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Infections
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475968/ https://www.ncbi.nlm.nih.gov/pubmed/36104115 http://dx.doi.org/10.1136/rmdopen-2022-002293

Ejemplares similares

Facilitators and barriers for vaccination in patients with inflammatory rheumatic musculoskeletal diseases: a prospective cohort study
por: Andreica, Ioana, et al.
Publicado: (2023)

Effectiveness and safety of a biosimilar-to-biosimilar switch of the TNF inhibitor etanercept in patients with chronic inflammatory rheumatic diseases
por: Kiltz, Uta, et al.
Publicado: (2022)

SARS-CoV-2 vaccination willingness and predictors in patients with chronic inflammatory rheumatic diseases (CIRD) and without CIRD
por: Roman, Iulia, et al.
Publicado: (2022)

Inferior humoral and sustained cellular immunity against wild-type and omicron variant of concern in hemodialysis patients immunized with 3 SARS-CoV-2 vaccine doses compared with 4 doses
por: Cinkilic, Okan, et al.
Publicado: (2022)

Inferior cellular and humoral immunity against Omicron and Delta variants of concern compared with SARS-CoV-2 wild type in hemodialysis patients immunized with 4 SARS-CoV-2 vaccine doses
por: Anft, Moritz, et al.
Publicado: (2022)

Are patients with rheumatic diseases on immunosuppressive therapies protected against preventable infections? A cross-sectional cohort study
por: Kiltz, Uta, et al.
Publicado: (2021)

Treatment with adalimumab in patients with chronic inflammatory rheumatic diseases: a study of treatment trajectories on a patient level in routine care
por: Redeker, Imke, et al.
Publicado: (2023)

A third vaccine dose substantially improves humoral and cellular SARS-CoV-2 immunity in renal transplant recipients with primary humoral nonresponse
por: Westhoff, Timm H., et al.
Publicado: (2021)

Facilitators and barriers of vaccine uptake in patients with autoimune inflammatory rheumatic disease: a scoping review
por: Neusser, Silke, et al.
Publicado: (2022)

Superior humoral immunity in vaccinated SARS-CoV-2 convalescence as compared to SARS-COV-2 infection or vaccination
por: Paniskaki, Krystallenia, et al.
Publicado: (2022)

Epitope similarity cannot explain the pre-formed T cell immunity towards structural SARS-CoV-2 proteins
por: Stervbo, Ulrik, et al.
Publicado: (2020)

SARS-CoV-2 vaccination improves HBV seroconversion rate through heterological immunity
por: Anft, Moritz, et al.
Publicado: (2023)

Significant Fade of Neutralizing Antibodies and Stable Cellular Immunity in 4 Times COVID-19 Vaccinated Noninfected Compared to COVID-19 Convalescent and 3 Times Vaccinated Hemodialysis Patients
por: Anft, Moritz, et al.
Publicado: (2023)

Immunogenicity of Bivalent Omicron BA.4/5–Adapted Vaccine in Hemodialysis Patients
por: Anft, Moritz, et al.
Publicado: (2023)

Dysfunctional high-density lipoprotein in chronic inflammatory rheumatic diseases
por: Waldecker-Gall, Sabina, et al.
Publicado: (2023)

beadplexr: reproducible and automated analysis of multiplex bead assays
por: Stervbo, Ulrik, et al.
Publicado: (2018)

Fading SARS-CoV-2 humoral VOC cross-reactivity and sustained cellular immunity in convalescent children and adolescents
por: Paniskaki, Krystallenia, et al.
Publicado: (2023)

SARS-CoV-2–reactive cellular and humoral immunity in hemodialysis population
por: Anft, Moritz, et al.
Publicado: (2021)

Detection of pre-existing SARS-CoV-2-reactive T cells in unexposed renal transplant patients
por: Anft, Moritz, et al.
Publicado: (2021)

A Vector-Based Vaccine Dose After 3 Doses of mRNA-Based COVID-19 Vaccination Does Not Substantially Improve Humoral SARS-CoV-2 Immunity in Renal Transplant Recipients
por: Roch, Toralf, et al.
Publicado: (2022)

Empagliflozin Reduces Interleukin-6 Levels in Patients with Heart Failure
por: Gotzmann, Michael, et al.
Publicado: (2023)

Improved cellular and humoral immunity upon a second BNT162b2 and mRNA-1273 boost in prime-boost vaccination no/low responders with end-stage renal disease
por: Stervbo, Ulrik, et al.
Publicado: (2021)

Management of Axial Spondyloarthritis – Insights into Upadacitinib
por: Braun, Jürgen, et al.
Publicado: (2022)

Case report: SARS-CoV-2 specific T-cells are associated with myocarditis after COVID-19 vaccination with mRNA-1273
por: Stervbo, Ulrik, et al.
Publicado: (2023)

Superior cellular and humoral immunity toward SARS-CoV-2 reference and alpha and beta VOC strains in COVID-19 convalescent as compared to the prime boost BNT162b2-vaccinated dialysis patients
por: Blazquez-Navarro, Arturo, et al.
Publicado: (2021)

Low avidity circulating SARS-CoV-2 reactive CD8+ T cells with proinflammatory TEMRA phenotype are associated with post-acute sequelae of COVID-19
por: Paniskaki, Krystallenia, et al.
Publicado: (2023)

Secukinumab in axial spondyloarthritis: a narrative review of clinical evidence
por: Braun, Jürgen, et al.
Publicado: (2021)

Immune monitoring facilitates the clinical decision in multifocal COVID-19 of a pancreas-kidney transplant patient
por: Babel, Nina, et al.
Publicado: (2020)

Robust hepatitis B vaccine-reactive T cell responses in failed humoral immunity
por: Awad, Gounwa, et al.
Publicado: (2021)

Drohende Corona-Endemie in einer rheumatologischen Spezialklinik – relative Entwarnung durch konsequente Testung
por: Andreica, I., et al.
Publicado: (2021)

Repeated Changes to the Gravitational Field Negatively Affect the Serum Concentration of Select Growth Factors and Cytokines
por: Stervbo, Ulrik, et al.
Publicado: (2019)

Detection of SARS‐CoV‐2‐specific memory B cells to delineate long‐term COVID‐19 immunity
por: Thieme, Constantin J., et al.
Publicado: (2021)

Propionate supplementation promotes the expansion of peripheral regulatory T-Cells in patients with end-stage renal disease
por: Meyer, Fabian, et al.
Publicado: (2020)

Do patients with ankylosing spondylitis adapt to their disease? Evidence from a ‘then-test’ in patients treated with TNF inhibitors
por: Essers, Ivette, et al.
Publicado: (2015)

Severe Acute Respiratory Syndrome Coronavirus 2 Cross-Reactive B and T Cell Responses in Kidney Transplant Patients
por: Paniskaki, Krystallenia, et al.
Publicado: (2022)

Attitude towards and perception of individual safety after SARS-CoV-2 vaccination among German cancer patients
por: Overheu, Oliver, et al.
Publicado: (2022)

Robust T Cell Response Toward Spike, Membrane, and Nucleocapsid SARS-CoV-2 Proteins Is Not Associated with Recovery in Critical COVID-19 Patients
por: Thieme, Constantin J., et al.
Publicado: (2020)

Differential T cell response against BK virus regulatory and structural antigens: A viral dynamics modelling approach
por: Blazquez-Navarro, Arturo, et al.
Publicado: (2018)

Allograft infiltration and meningoencephalitis by SARS-CoV-2 in a pancreas-kidney transplant recipient
por: Westhoff, Timm H., et al.
Publicado: (2020)

Immune Response in Moderate to Critical Breakthrough COVID-19 Infection After mRNA Vaccination
por: Paniskaki, Krystallenia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vso8i8e2nc0d2p173qihgajmu2